Milestone: Creating Innovative Solutions Milestone Home
 
image thru microscope
Symposia Contact Home

CPSA Digest 2002

Emerging Standards for Drug Discovery and Development:
Perspectives on Technology, Strategy and Relationships

October 8-10, 2002

CPSA Digest 2002

Overview
Day 1: Proceedings | Plenary
Day 2: Proceedings
Day 3: Proceedings

CPSA 2002 Sponsors

CPSA Digest Archive
CPSA Digest 2000
CPSA Digest 2001
CPSA Digest 2002 >>
CPSA Digest 2003
CPSA Digest 2004


Proceedings -Tuesday, October 8, 2002

TuOD1



The Role of Complete De Novo Peptide Sequencing in Protein Characterization

Al Yergey, National Institutes of Health

A powerful technique for protein identification is known as de novo peptide sequencing. Proteins can be characterized either globally (all proteins present) or specifically (by function, location or partners). Any characterization of proteins requires the separation and isolation of components with their subsequent identification. Components can be separated by techniques such as immunoprecipitation, electrophoresis and chromatography; identification can be made by mass spectrometry, Edman sequencing or antibody reactions.

The standard approach to protein identification uses mass spectrometry for identification. A mixture of proteins is separated on a gel, selected proteins are removed from that gel, a digestion with protease is performed to generate peptides and then partial or full peptide sequencing is performed. This isolated peptide mixture is analyzed by mass spectrometry to give a list of peptide masses that can be searched against standard peptide databases.

Peptide sequencing uses two stage mass analysis—quad, trap, hybrid or TOF-TOF. The peptides are charged and separated according to their mass to charge ratios. From the first stage mass spectrum a precursor mass and fragment are selected and fragmentation is performed in the second stage of analysis. Since the fragmentation can occur anywhere along the peptide, a spectrum of the observed mass to charge ratios is generated. The different amino acids within a peptide each have different masses and so the spectrum of a peptide is usually characteristic of the peptide sequence.

The peptides that are identified can sometimes be adequate to identify the protein. However, there can be problems with this technique. Note that the quality of the "hit" depends on the length of the sequence tag and the number of peptides matched. The majority of "hits" involve a single peptide; isobaric peptides exist at both ends, leading to an ambiguity in the sequence at these points. A large percentage (>50%) of the MS/MS spectra are not used due to reasons such as a poor quality spectrum, a non-protein contaminant or an unknown protein. In order to maximize the information learned, the spectral information obtained needs to be better utilized. Toward accomplishing this goal, algorithms are used for searching protein and nucleic acid databases for similarities to query sequences.

The main technique for tandem mass spectrometry is electrospray ionization followed by MS/MS in an ion trap or a triple quadrupole instrument. Many commercial MALDI mass spectrometers are used to perform sequencing by a technique called post-source decay, in which the spectrum is acquired in a series of steps and summed to give the product ion spectrum. However, using newer designs, true MS/MS experiments can be conducted using MALDI-MS. These instruments have two TOF analyzers linked in tandem and are set up to give high throughput and MS/MS spectra with many fragments and high mass resolution. Several examples were presented to illustrate peptide fragmentation patterns and problem solving of peptide sequencing using an "alligator algorithm."



Return to Proceedings »



overview | training | workshops | consulting | symposia | contact | home